Chemed Corporation $CHE Shares Sold by Riverbridge Partners LLC

Key Points

• Riverbridge Partners LLC cut its stake by 5%, selling 2,856 shares and retaining 54,119 shares (about 0.38% of Chemed) valued at roughly $23.16 million at quarter-end.
• Chemed missed estimates for the quarter with EPS of $6.42 versus $7.02 expected and revenue of $639.34M versus $659.09M, but issued FY2026 guidance of 23.25–24.25 EPS (analysts average 21.43).
• Shares trade below their 50- and 200-day averages with a market cap of $5.11B and a consensus Wall Street rating of Hold (average target $498) after several analyst downgrades.

Riverbridge Partners LLC cut its stake in Chemed Corporation (NYSE:CHE - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 54,119 shares of the company's stock after selling 2,856 shares during the period. Riverbridge Partners LLC owned about 0.38% of Chemed worth $23,155,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Signal Advisors Wealth LLC increased its holdings in Chemed by 4.4% during the 4th quarter. Signal Advisors Wealth LLC now owns 18,239 shares of the company's stock worth $7,804,000 after purchasing an additional 773 shares during the period. First Heartland Consultants Inc. grew its position in shares of Chemed by 27.5% during the fourth quarter. First Heartland Consultants Inc. now owns 1,224 shares of the company's stock worth $524,000 after buying an additional 264 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Chemed by 773.5% during the fourth quarter. SG Americas Securities LLC now owns 26,466 shares of the company's stock worth $11,324,000 after buying an additional 23,436 shares in the last quarter. Wealth Enhancement Advisory Services LLC increased its stake in shares of Chemed by 8.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 4,643 shares of the company's stock worth $2,048,000 after buying an additional 354 shares during the period. Finally, GAMMA Investing LLC increased its stake in shares of Chemed by 64.8% during the fourth quarter. GAMMA Investing LLC now owns 290 shares of the company's stock worth $124,000 after buying an additional 114 shares during the period. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Trading Down 0.7%

Shares of Chemed stock opened at $371.46 on Friday. The company has a fifty day simple moving average of $429.83 and a 200-day simple moving average of $436.19. The stock has a market cap of $5.11 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.48 and a beta of 0.46. Chemed Corporation has a 12-month low of $368.44 and a 12-month high of $623.60.

Chemed (NYSE:CHE - Get Free Report) last announced its earnings results on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million during the quarter, compared to analyst estimates of $659.09 million. Chemed had a net margin of 10.48% and a return on equity of 25.66%. The firm's revenue for the quarter was down .1% compared to the same quarter last year. During the same period last year, the company earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 annualized dividend and a yield of 0.6%. The ex-dividend date was Monday, February 23rd. Chemed's payout ratio is 13.06%.

Wall Street Analyst Weigh In

Several research analysts have commented on CHE shares. Jefferies Financial Group cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Thursday, January 22nd. Zacks Research cut shares of Chemed from a "hold" rating to a "strong sell" rating in a research report on Wednesday, March 4th. Royal Bank Of Canada reiterated a "sector perform" rating and set a $422.00 target price (down from $572.00) on shares of Chemed in a research note on Friday, February 27th. Oppenheimer dropped their target price on Chemed from $580.00 to $500.00 and set an "outperform" rating on the stock in a report on Friday, February 27th. Finally, Weiss Ratings restated a "hold (c-)" rating on shares of Chemed in a research note on Wednesday, January 21st. Two investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $498.00.

Insider Transactions at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total transaction of $806,360.00. Following the completion of the sale, the chief executive officer directly owned 93,719 shares of the company's stock, valued at $37,785,626.42. This represents a 2.09% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.29% of the stock is owned by company insiders.

Chemed Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.